Fiorino, Gionata
Fiorino, Gionata
Dipartimento Scienze Biomediche
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
2017-01-01 Gomollon, F; Dignass, A; Annese, V; Tilg, H; Van Assche, G; Lindsay, Jo; Peyrin-Biroulet, L; Cullen, Gj; Daperno, M; Kucharzik, T; Rieder, F; Almer, S; Armuzzi, A; Harbord, M; Langhorst, J; Sans, M; Chowers, Y; Fiorino, G; Juillerat, P; Mantzaris, Gj; Rizzello, F; Vavricka, S; Gionchetti, P
A HEALTH TECHNOLOGY-RELATED COST DESCRIPTION CONCERNING ITALIAN IBD CENTRES DEALING WITH CROHN'S DISEASE: RESULTS FROM SOLE STUDY
2014-01-01 Lazzaro, C; Cappello, M; Cortelezzi, C; Costantino, G; Fiorino, G; Mastronardi, M; Giannotta, M; Galletti, B; Cicala, M; di Prampero, Sv; Gualberti, G; Caprioli, F; Gasbarrini, A; Fattore, G
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis
2019-01-01 Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; Bonovas, S; D'Haens, G; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis
2019-01-01 Fiorino, G; Sturniolo, Gc; Bossa, F; Cassinotti, A; Di Sabatino, A; Giuffrida, P; Danese, S
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT
2017-01-01 Armuzzi, A; Fiorino, G; Variola, A; Manetti, N; Fries, W; Rizzuto, G; Bossa, F; Cappello, M; Biancone, L; D'Inca, R; Cantoro, L; Castiglione, F; Principi, M; Annunziata, Ml; Di Girolamo, M; Terpin, Mm; Cortelezzi, Cc; Costa, F; Amato, A; Di Sabatino, A; Saibeni, S; Meucci, G; Petruzzellis, C; Tari, R; Guglielmi, Fw; Guidi, L; Danese, S; Rogai, F; Geccherle, A; Ventra, A; Orlando, A; Andriulli, A; Scrivo, B; Troncone, E; Caccaro, R; Kohn, A; Nardone, Om; Pugliese, D; Annese, V
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience
2011-01-01 Fiorino, G; Bonifacio, C; Padrenostro, M; Sposta, Fm; Balzarini, L; Repici, A; Malesci, A; Danese, S
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience.
2010-01-01 Fiorino, G.; Bonifacio, C.; Minuti, F.; Repici, A.; Spinelli, A.; Fries, W.; Malesci, A.; Balzarini, L.; Danese, S.
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis
2019-01-01 Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; D'Haens, G; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX® FOR MILD-TO-MODERATE ULCERATIVE COLITIS
2019-01-01 Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; D'Haens, Gr; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
2019-01-01 Beeg, M; Nobili, A; Orsini, B; Rogai, F; Gilardi, D; Fiorino, G; Danese, S; Salmona, M; Garattini, S; Gobbi, M
Accuracy of a New Fujiifilm Blue Light Prototype in Predicting the Histology of Subcentimetric Polyps
2016-01-01 Repici, A; Ciscato, C; Amato, L; Di Leo, M; Ferrara, E; Carrara, S; Anderloni, A; Galtieri, Pa; Sferrazza, S; Furfaro, F; Maselli, R; Carlani, E; Fiorino, G; Hassan, C
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study
2018-01-01 Allocca, M; Fiorino, G; Bonovas, S; Furfaro, F; Gilardi, D; Argollo, M; Magnoni, P; Peyrin-Biroulet, L; Danese, S
Acute Severe Colitis: Infliximab and/or Cyclosporine?
2011-01-01 Fabro, M; Szabo, H; Terrosu, G; Avellini, C; Tabuso, M; Fiorino, G; Sorrentino, D.
Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?
2016-01-01 Fiorino, G; Danese, S
Adalimumab for the treatment of pediatric Crohn's disease
2015-01-01 Nuti, F; Fiorino, G; Danese, S
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience
2011-01-01 Fiorino, G.; Szabò, H.; Walter, F.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S.
Adalimumab in ulcerative colitis: hypes and hopes
2011-01-01 Fiorino, G.; Peyrin-Biroulet, L.; Repici, A.; Malesci, A.
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report
2010-01-01 Fiorino, G.; Repici, A.; Malesci, A.; Danese, S.
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study
2024-01-01 D'Amico, Ferdinando; Massimino, Luca; Palmieri, Giulia; Dal Buono, Arianna; Gabbiadini, Roberto; Caron, Benedicte; Moreira, Paula; Silva, Isabel; Bosca‐watts, Maia; Innocenti, Tommaso; Dragoni, Gabriele; Bezzio, Cristina; Zilli, Alessandra; Furfaro, Federica; Saibeni, Simone; Chaparro, María; García, María José; Michalopoulos, George; Viazis, Nikos; Mantzaris, Gerassimos J.; Ellul, Pierre; Gisbert, Javier P.; Magro, Fernando; Peyrin‐biroulet, Laurent; Armuzzi, Alessandro; Ungaro, Federica; Danese, Silvio; Fiorino, Gionata; Allocca, Mariangela
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
2022-01-01 Onali, S; Pugliese, D; Caprioli, Fa; Orlando, A; Biancone, L; Nardone, Om; Imperatore, N; Fiorino, G; Cappello, M; Viola, A; Principi, Mb; Bezzio, C; Aratari, A; Carparelli, S; Mazzuoli, S; Manguso, F; Grossi, L; Bodini, G; Ribaldone, D; Mocci, G; Miranda, A; Minerba, L; Favale, A; Grova, M; Scucchi, L; Segato, S; Fries, W; Castiglione, F; Armuzzi, A; Fantini, Mc
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management | 1-gen-2017 | Gomollon, F; Dignass, A; Annese, V; Tilg, H; Van Assche, G; Lindsay, Jo; Peyrin-Biroulet, L; Cullen, Gj; Daperno, M; Kucharzik, T; Rieder, F; Almer, S; Armuzzi, A; Harbord, M; Langhorst, J; Sans, M; Chowers, Y; Fiorino, G; Juillerat, P; Mantzaris, Gj; Rizzello, F; Vavricka, S; Gionchetti, P | |
A HEALTH TECHNOLOGY-RELATED COST DESCRIPTION CONCERNING ITALIAN IBD CENTRES DEALING WITH CROHN'S DISEASE: RESULTS FROM SOLE STUDY | 1-gen-2014 | Lazzaro, C; Cappello, M; Cortelezzi, C; Costantino, G; Fiorino, G; Mastronardi, M; Giannotta, M; Galletti, B; Cicala, M; di Prampero, Sv; Gualberti, G; Caprioli, F; Gasbarrini, A; Fattore, G | |
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis | 1-gen-2019 | Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; Bonovas, S; D'Haens, G; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L | |
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis | 1-gen-2019 | Fiorino, G; Sturniolo, Gc; Bossa, F; Cassinotti, A; Di Sabatino, A; Giuffrida, P; Danese, S | |
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT | 1-gen-2017 | Armuzzi, A; Fiorino, G; Variola, A; Manetti, N; Fries, W; Rizzuto, G; Bossa, F; Cappello, M; Biancone, L; D'Inca, R; Cantoro, L; Castiglione, F; Principi, M; Annunziata, Ml; Di Girolamo, M; Terpin, Mm; Cortelezzi, Cc; Costa, F; Amato, A; Di Sabatino, A; Saibeni, S; Meucci, G; Petruzzellis, C; Tari, R; Guglielmi, Fw; Guidi, L; Danese, S; Rogai, F; Geccherle, A; Ventra, A; Orlando, A; Andriulli, A; Scrivo, B; Troncone, E; Caccaro, R; Kohn, A; Nardone, Om; Pugliese, D; Annese, V | |
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience | 1-gen-2011 | Fiorino, G; Bonifacio, C; Padrenostro, M; Sposta, Fm; Balzarini, L; Repici, A; Malesci, A; Danese, S | |
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. | 1-gen-2010 | Fiorino, G.; Bonifacio, C.; Minuti, F.; Repici, A.; Spinelli, A.; Fries, W.; Malesci, A.; Balzarini, L.; Danese, S. | |
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis | 1-gen-2019 | Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; D'Haens, G; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L | |
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX® FOR MILD-TO-MODERATE ULCERATIVE COLITIS | 1-gen-2019 | Danese, S; Hart, A; Dignass, A; Fiorino, G; Louis, E; D'Haens, Gr; Dotan, I; Rogler, G; Paridaens, K; Peyrin-Biroulet, L | |
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies | 1-gen-2019 | Beeg, M; Nobili, A; Orsini, B; Rogai, F; Gilardi, D; Fiorino, G; Danese, S; Salmona, M; Garattini, S; Gobbi, M | |
Accuracy of a New Fujiifilm Blue Light Prototype in Predicting the Histology of Subcentimetric Polyps | 1-gen-2016 | Repici, A; Ciscato, C; Amato, L; Di Leo, M; Ferrara, E; Carrara, S; Anderloni, A; Galtieri, Pa; Sferrazza, S; Furfaro, F; Maselli, R; Carlani, E; Fiorino, G; Hassan, C | |
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study | 1-gen-2018 | Allocca, M; Fiorino, G; Bonovas, S; Furfaro, F; Gilardi, D; Argollo, M; Magnoni, P; Peyrin-Biroulet, L; Danese, S | |
Acute Severe Colitis: Infliximab and/or Cyclosporine? | 1-gen-2011 | Fabro, M; Szabo, H; Terrosu, G; Avellini, C; Tabuso, M; Fiorino, G; Sorrentino, D. | |
Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond? | 1-gen-2016 | Fiorino, G; Danese, S | |
Adalimumab for the treatment of pediatric Crohn's disease | 1-gen-2015 | Nuti, F; Fiorino, G; Danese, S | |
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience | 1-gen-2011 | Fiorino, G.; Szabò, H.; Walter, F.; Malesci, A.; Peyrin-Biroulet, L.; Danese, S. | |
Adalimumab in ulcerative colitis: hypes and hopes | 1-gen-2011 | Fiorino, G.; Peyrin-Biroulet, L.; Repici, A.; Malesci, A. | |
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report | 1-gen-2010 | Fiorino, G.; Repici, A.; Malesci, A.; Danese, S. | |
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study | 1-gen-2024 | D'Amico, Ferdinando; Massimino, Luca; Palmieri, Giulia; Dal Buono, Arianna; Gabbiadini, Roberto; Caron, Benedicte; Moreira, Paula; Silva, Isabel; Bosca‐watts, Maia; Innocenti, Tommaso; Dragoni, Gabriele; Bezzio, Cristina; Zilli, Alessandra; Furfaro, Federica; Saibeni, Simone; Chaparro, María; García, María José; Michalopoulos, George; Viazis, Nikos; Mantzaris, Gerassimos J.; Ellul, Pierre; Gisbert, Javier P.; Magro, Fernando; Peyrin‐biroulet, Laurent; Armuzzi, Alessandro; Ungaro, Federica; Danese, Silvio; Fiorino, Gionata; Allocca, Mariangela | |
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors | 1-gen-2022 | Onali, S; Pugliese, D; Caprioli, Fa; Orlando, A; Biancone, L; Nardone, Om; Imperatore, N; Fiorino, G; Cappello, M; Viola, A; Principi, Mb; Bezzio, C; Aratari, A; Carparelli, S; Mazzuoli, S; Manguso, F; Grossi, L; Bodini, G; Ribaldone, D; Mocci, G; Miranda, A; Minerba, L; Favale, A; Grova, M; Scucchi, L; Segato, S; Fries, W; Castiglione, F; Armuzzi, A; Fantini, Mc |